UPL Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/4qlszaj34bltt9pai25yhfla.pdf

Key Takeaways


Tariff & U.S. Market Dynamics

Mike Frank: "this year, our prepay dollars in the U.S. was at a record high and increased by about 25% over the prepay level of last year. And so, I think that's a solid indication that at least in our business, we've got strong momentum and retailers and distributors are indicating they're going to do more business with us heading into the 2026 calendar year."

Regional & Portfolio Performance


Margins & Cost Structure


Advanta IPO & Portfolio Restructuring

Toshan Tamhane: "we believe that the needs of crop protection in terms of the cash flows, capital allocation are very different from that of the seeds business. As you would have seen globally, Corteva has also announced a split between crop protection and seeds because just those two businesses are fundamentally different, and we believe Advanta as the eighth largest seeds player globally has a journey and destiny of its own."

Product Pipeline & Innovation

Mike Frank: "Our field trial results and the feedback from growers that have visited our trials give us confidence that this product will be a high-impact addition to our leading sucking pest portfolio."

Balance Sheet & Liquidity


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year revenue growth4% to 8% revenue growthFY26
Full-year EBITDA growth12% to 16% EBITDA growthFY26
Working capital daysAround 70 daysMarch 2026
Net debt-to-EBITDA1.6x to 1.8x (down from 2.1x)FY26 year-end
New product launch revenueExceed $130 mn targetFY26
Advanta IPO or restructuringDRHP filed; IPO/restructuring within window1 to 3 years
New insecticide launchMajor sucking-pest portfolio additionNext year (FY27)
Q4 tariff impact (conditional)$30 mn+ net unoffsetable if 50% rate holdsQ4 FY26

Key Metrics

MetricQ3 FY26
Revenue₹12,269 cr, +12% YoY
Volume growth+8% YoY
Contribution margin~43%, expanded 160 bps YoY
Contribution₹5,227 cr, +17% YoY
EBITDA₹2,434 cr, +13% YoY; margin at ~20%
Profit before tax₹671 cr, +90% YoY
Operating PATMI₹452 cr, +45% YoY (adjusted for one-off tax reversal in Q3 FY25)
Net finance costs₹639 cr, down from ₹704 cr YoY
Net debt₹23,317 cr ($2.594 bn), down ₹2,553 cr YoY
Net debt-to-EBITDA2.5x, improved from 3.8x YoY
Net working capital days116 days, up 9 days YoY
UPL Corp revenue growth+8% YoY
UPL Corp EBITDA margin~19%
Advanta revenue growth+22% YoY; +14% volume growth in seeds
Advanta EBITDA growth+22% YoY
SUPERFORM revenue growth−11% YoY; super specialty business +42%
Full-year FY26 revenue guidance4% to 8% growth
Full-year FY26 EBITDA guidance12% to 16% growth
U.S. prepay growth+25% over prior year
Tariff impact on EBITDA (YTD)~$8 mn
Expected credit loss provisioning~$5 mn in Q3